Mirae Asset Global Etfs Holdings Ltd. Keros Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 15,183 shares of KROS stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,183Holding current value
$1.03 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KROS
# of Institutions
160Shares Held
27.6MCall Options Held
28.7KPut Options Held
1.8K-
Black Rock Inc. New York, NY2.51MShares$171 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$120 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.6MShares$109 Million0.12% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.53MShares$104 Million8.43% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$86.5 Million1.4% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.76B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...